Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
| Article Title | Original Publication Date | Journal Sort ascending | Bone Marrow Disease |
|---|---|---|---|
| Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) | |
| The Problem of TP53-Mutant MDS/AML | Clinical Lymphoma , Myeloma & Leukemia | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | |
| Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) | |
| New Approaches for Anemia in MDS | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) | |
| Pitfalls in Assessing Response to Treatment in MDS | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) | |
| SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) | |
| Kidney involvement in myelodysplastic syndromes | Clinical Kidney Journal | Myelodysplastic Syndromes (MDS) | |
| Silver lining: reduced relapse with chronic GVHD after transplant for MDS | Clinical Cancer Research: an official Journal of the American Association of Cancer Research | Graft Versus Host Disease (GVHD), Myelodysplastic Syndromes (MDS) | |
| Phase 2 Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes | Clinical Cancer Research: an official Journal of the American Association of Cancer Research | Myelodysplastic Syndromes (MDS) | |
| Considerations for Drug Development in Myelodysplastic Syndromes | Clinical Cancer Research | Myelodysplastic Syndromes (MDS) |